drugset / Trial / NCT00969085

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

NCT00969085

Phase 2 Withdrawn M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn if treatment with curcumin can help to decrease the size of lesions and/or decrease itching in patients with MF or SS. The safety of curcumin will also be studied.

Timeline

Start
2012-11
Primary completion
2014-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 8 g Oral